Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Effects of angiogenic factors, antagonists, and podocyte injury on development of proteinuria in preeclampsia.

Chen G, Zhang L, Jin X, Zhou Y, Niu J, Chen J, Gu Y.

Reprod Sci. 2013 May;20(5):579-88. doi: 10.1177/1933719112459227.

2.

Podocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective study.

Craici IM, Wagner SJ, Bailey KR, Fitz-Gibbon PD, Wood-Wentz CM, Turner ST, Hayman SR, White WM, Brost BC, Rose CH, Grande JP, Garovic VD.

Hypertension. 2013 Jun;61(6):1289-96. doi: 10.1161/HYPERTENSIONAHA.113.01115.

3.

Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.

Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.

J Hypertens. 2012 Nov;30(11):2173-81. doi: 10.1097/HJH.0b013e328357c0c9.

PMID:
22902831
4.

Urinary placental growth factor and risk of preeclampsia.

Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, Blink AL, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA.

JAMA. 2005 Jan 5;293(1):77-85.

PMID:
15632339
5.

The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia.

Pinheiro CC, Rayol P, Gozzani L, Reis LM, Zampieri G, Dias CB, Woronik V.

Prenat Diagn. 2014 Nov;34(11):1084-92. doi: 10.1002/pd.4432.

PMID:
24916790
6.

Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.

Buhimschi CS, Norwitz ER, Funai E, Richman S, Guller S, Lockwood CJ, Buhimschi IA.

Am J Obstet Gynecol. 2005 Mar;192(3):734-41.

PMID:
15746665
7.

[Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].

Gao J, Shen J, Jiang Y, Zhou X, Qi H, Liu X, Liu J, Yang J, Bian X.

Zhonghua Fu Chan Ke Za Zhi. 2014 Jan;49(1):22-5. Chinese.

PMID:
24694913
8.

Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.

Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ.

Circulation. 2010 Aug 3;122(5):478-87. doi: 10.1161/CIRCULATIONAHA.109.895458. Erratum in: Circulation. 2011 Sep 13;124(11):e302.

9.

Circulating angiogenic factors and the risk of preeclampsia.

Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA.

N Engl J Med. 2004 Feb 12;350(7):672-83.

10.

First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.

Odibo AO, Rada CC, Cahill AG, Goetzinger KR, Tuuli MG, Odibo L, Macones GA, England SK.

J Perinatol. 2013 Sep;33(9):670-4. doi: 10.1038/jp.2013.33.

PMID:
23558430
11.

Fractional excretion of angiogenic factors in women with severe preeclampsia.

Buhimschi CS, Magloire L, Funai E, Norwitz ER, Kuczynski E, Martin R, Richman S, Guller S, Lockwood CJ, Buhimschi IA.

Obstet Gynecol. 2006 May;107(5):1103-13.

PMID:
16648417
12.

Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia.

Guseh SH, Feinberg BB, Dawood HY, Yamamoto HS, Fichorova RN, Burwick RM.

Am J Reprod Immunol. 2015 May;73(5):437-44. doi: 10.1111/aji.12349.

PMID:
25521546
13.

Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort.

Villa PM, Hämäläinen E, Mäki A, Räikkönen K, Pesonen AK, Taipale P, Kajantie E, Laivuori H.

BMC Pregnancy Childbirth. 2013 May 12;13:110. doi: 10.1186/1471-2393-13-110.

14.

Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.

Forest JC, Thériault S, Massé J, Bujold E, Giguère Y.

Clin Chem Lab Med. 2014 Aug;52(8):1169-78. doi: 10.1515/cclm-2013-0955.

PMID:
24535301
15.

Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.

Park HJ, Kim SH, Jung YW, Shim SS, Kim JY, Cho YK, Farina A, Zanello M, Lee KJ, Cha DH.

BMC Pregnancy Childbirth. 2014 Jan 20;14:35. doi: 10.1186/1471-2393-14-35.

16.

A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.

Sahay AS, Patil VV, Sundrani DP, Joshi AA, Wagh GN, Gupte SA, Joshi SR.

Hypertens Res. 2014 Aug;37(8):753-8. doi: 10.1038/hr.2014.71.

PMID:
24718301
17.

Accuracy of angiogenic biomarkers at ⩽20weeks' gestation in predicting the risk of pre-eclampsia: A WHO multicentre study.

Widmer M, Cuesta C, Khan KS, Conde-Agudelo A, Carroli G, Fusey S, Karumanchi SA, Lapaire O, Lumbiganon P, Sequeira E, Zavaleta N, Frusca T, Gülmezoglu AM, Lindheimer MD.

Pregnancy Hypertens. 2015 Oct;5(4):330-8. doi: 10.1016/j.preghy.2015.09.004.

PMID:
26597750
18.

Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.

Govender N, Naicker T, Rajakumar A, Moodley J.

Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):100-5. doi: 10.1016/j.ejogrb.2013.05.021.

PMID:
23806447
19.

Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia.

Molvarec A, Szarka A, Walentin S, Beko G, Karádi I, Prohászka Z, Rigó J Jr.

Reprod Biol Endocrinol. 2011 Sep 9;9:124. doi: 10.1186/1477-7827-9-124.

20.

Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.

Rana S, Hacker MR, Modest AM, Salahuddin S, Lim KH, Verlohren S, Perschel FH, Karumanchi SA.

Hypertension. 2012 Aug;60(2):451-8. doi: 10.1161/HYPERTENSIONAHA.112.195065.

Items per page

Supplemental Content

Support Center